Back to Search Start Over

Characterization of Early and Late Damage in a Mouse Model of Pelvic Radiation Disease.

Authors :
Vitali, Roberta
Palone, Francesca
De Stefano, Ilaria
Fiorente, Chiara
Novelli, Flavia
Pasquali, Emanuela
Fratini, Emiliano
Tanori, Mirella
Leonardi, Simona
Tanno, Barbara
Colantoni, Eleonora
Soldi, Sara
Galletti, Serena
Grimaldi, Maria
Morganti, Alessio Giuseppe
Fuccio, Lorenzo
Pazzaglia, Simonetta
Pioli, Claudio
Mancuso, Mariateresa
Vesci, Loredana
Source :
International Journal of Molecular Sciences; May2023, Vol. 24 Issue 10, p8800, 19p
Publication Year :
2023

Abstract

Pelvic radiation disease (PRD), a frequent side effect in patients with abdominal/pelvic cancers treated with radiotherapy, remains an unmet medical need. Currently available preclinical models have limited applications for the investigation of PRD pathogenesis and possible therapeutic strategies. In order to select the most effective irradiation protocol for PRD induction in mice, we evaluated the efficacy of three different locally and fractionated X-ray exposures. Using the selected protocol (10 Gy/day × 4 days), we assessed PRD through tissue (number and length of colon crypts) and molecular (expression of genes involved in oxidative stress, cell damage, inflammation, and stem cell markers) analyses at short (3 h or 3 days after X-ray) and long (38 days after X-rays) post-irradiation times. The results show that a primary damage response in term of apoptosis, inflammation, and surrogate markers of oxidative stress was found, thus determining a consequent impairment of cell crypts differentiation and proliferation as well as a local inflammation and a bacterial translocation to mesenteric lymph nodes after several weeks post-irradiation. Changes were also found in microbiota composition, particularly in the relative abundance of dominant phyla, related families, and in alpha diversity indices, as an indication of dysbiotic conditions induced by irradiation. Fecal markers of intestinal inflammation, measured during the experimental timeline, identified lactoferrin, along with elastase, as useful non-invasive tools to monitor disease progression. Thus, our preclinical model may be useful to develop new therapeutic strategies for PRD treatment. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
16616596
Volume :
24
Issue :
10
Database :
Complementary Index
Journal :
International Journal of Molecular Sciences
Publication Type :
Academic Journal
Accession number :
163966465
Full Text :
https://doi.org/10.3390/ijms24108800